Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial
Recommended Citation
Thompson AM, Fernandez JM, Shih T, Hamzavi I, Hsiao JL, and Shi VY. Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial. J Dermatolog Treat 2021;1-3.
Document Type
Article
Publication Date
9-27-2021
Publication Title
The Journal of dermatological treatment
Abstract
The waxing-and-waning nature of hidradenitis suppurativa (HS), complex treatment plans, along with variable responsiveness to therapy, can create management challenges for patients. In this pilot cross-over randomized controlled trial, we aim to evaluate the effectiveness a HS-written action plan (HSWAP) on patient disease understanding and confidence in recognizing flares and adjusting management. Participants were randomized into a pre-crossover control group that received a verbal consultation (VC)-only, and an intervention group which received the VC + HSWAP. The pre-crossover control group then crossed over (post-crossover control) to also receive the VC + HSWAP (ClinicalTrials.gov Identifier: NCT04600375). Patient comprehension of their disease and management steps was high after both a thorough VC and HSWAPs. However, the majority of patients prefer receiving both a VC and a HSWAP. After the addition of the HSWAP, pre-crossover control group patients' understanding and confidence of their disease and management plan increased across all surveyed questions.
PubMed ID
34579620
ePublication
ePub ahead of print
First Page
1
Last Page
3
